Real-Time Imaging of Dynamic Cell Reprogramming with Nanosensors.
Christian WirajaDavid C YeoKhek-Chian ThamSharon W T ChewXinhong LimChenjie XuPublished in: Small (Weinheim an der Bergstrasse, Germany) (2018)
Cellular reprogramming, the process by which somatic cells regain pluripotency, is relevant in many disease modeling, therapeutic, and drug discovery applications. Molecular evaluation of reprogramming (e.g., polymerase chain reaction, immunostaining) is typically disruptive, and only provides snapshots of phenotypic traits. Gene reporter constructs facilitate live-cell evaluation but is labor intensive and may risk insertional mutagenesis during viral transfection. Herein, the utilization of a non-integrative nanosensor is demonstrated to visualize key reprogramming events in situ within live cells. Principally based on sustained intracellular release of encapsulated molecular probes, nanosensors successfully monitored mesenchymal-epithelial transition, pluripotency acquisition, and transdifferentiation events. Tracking the dynamic expression of four pivotal biomarkers (i.e., THY1, E-CADHERIN, OCT4, and GATA4 mRNA), nanosensor signal showed great agreement with polymerase chain reaction and gene reporter imaging (R2 > 0.9). Overall, such facile, versatile nanosensor enables real-time monitoring of low-frequency reprogramming events, thereby useful for high-throughput assessment, optimization, and biomarker-specific cell enrichment.
Keyphrases
- induced apoptosis
- drug discovery
- single cell
- crispr cas
- high throughput
- genome wide
- cell cycle arrest
- copy number
- high resolution
- cell therapy
- bone marrow
- sars cov
- single molecule
- poor prognosis
- transcription factor
- cell death
- mass spectrometry
- living cells
- dna methylation
- weight loss
- fluorescent probe
- gold nanoparticles
- bariatric surgery
- reduced graphene oxide